» Articles » PMID: 38619739

Mendelian Causes of Autoimmunity: the Lupus Phenotype

Overview
Journal J Clin Immunol
Publisher Springer
Date 2024 Apr 15
PMID 38619739
Authors
Affiliations
Soon will be listed here.
Abstract

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that is characterized by its large heterogeneity in terms of clinical presentation and severity. The pathophysiology of SLE involves an aberrant autoimmune response against various tissues, an excess of apoptotic bodies, and an overproduction of type-I interferon. The genetic contribution to the disease is supported by studies of monozygotic twins, familial clustering, and genome-wide association studies (GWAS) that have identified numerous risk loci. In the early 70s, complement deficiencies led to the description of familial forms of SLE caused by a single gene defect. High-throughput sequencing has recently identified an increasing number of monogenic defects associated with lupus, shaping the concept of monogenic lupus and enhancing our insights into immune tolerance mechanisms. Monogenic lupus (moSLE) should be suspected in patients with either early-onset lupus or syndromic lupus, in male, or in familial cases of lupus. This review discusses the genetic basis of monogenic SLE and proposes its classification based on disrupted pathways. These pathways include defects in the clearance of apoptotic cells or immune complexes, interferonopathies, JAK-STATopathies, TLRopathies, and T and B cell dysregulations.

Citing Articles

How (Ultra-)Rare Gene Variants Improve Our Understanding of More Common Autoimmune and Inflammatory Diseases.

Belot A, Tusseau M, Cognard J, Georgin-Lavialle S, Boursier G, Hedrich C ACR Open Rheumatol. 2025; 7(2):e70003.

PMID: 39964335 PMC: 11834591. DOI: 10.1002/acr2.70003.


Lupus Nephritis from Pathogenesis to New Therapies: An Update.

Roveta A, Parodi E, Brezzi B, Tunesi F, Zanetti V, Merlotti G Int J Mol Sci. 2024; 25(16).

PMID: 39201667 PMC: 11354900. DOI: 10.3390/ijms25168981.


Fish oil supplementation and risk of incident systemic lupus erythematosus: a large population-based prospective study.

Chen Y, Li Z, Gao Y, Xu B, Zhang W, Wu I Nutr J. 2024; 23(1):63.

PMID: 38862999 PMC: 11167923. DOI: 10.1186/s12937-024-00965-x.

References
1.
Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R . 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019; 78(9):1151-1159. DOI: 10.1136/annrheumdis-2018-214819. View

2.
Tsokos G, Lo M, Reis P, Sullivan K . New insights into the immunopathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol. 2016; 12(12):716-730. DOI: 10.1038/nrrheum.2016.186. View

3.
Lemke G . How macrophages deal with death. Nat Rev Immunol. 2019; 19(9):539-549. PMC: 6733267. DOI: 10.1038/s41577-019-0167-y. View

4.
Doran A, Yurdagul Jr A, Tabas I . Efferocytosis in health and disease. Nat Rev Immunol. 2019; 20(4):254-267. PMC: 7667664. DOI: 10.1038/s41577-019-0240-6. View

5.
Rose T, Dorner T . Drivers of the immunopathogenesis in systemic lupus erythematosus. Best Pract Res Clin Rheumatol. 2017; 31(3):321-333. DOI: 10.1016/j.berh.2017.09.007. View